Indoleamine 2,3-Dioxygenase (IDO); Silenced Dendritic Cell Vaccine with Ipilimumab in Treating Metastatic Melanoma Patients: A Case Report

Journal Title: Journal of Clinical & Cellular Immunology - Year 2023, Vol 14, Issue 3

Abstract

Immunotherapy has revolutionized the treatment landscape for metastatic melanoma. This case report presents the clinical course of a patient with metastatic melanoma who received combination therapy with ipilimumab, a CTLA-4 checkpoint inhibitor, and an Indoleamine 2,3-Dioxygenase (IDO)-silenced Dendritic Cell (DC) vaccine. The treatment approach aimed to enhance antitumour immunity by blocking immune checkpoints and activating dendritic cells. The patient demonstrated a significant clinical response, indicating the diversification and potentiation of the antitumour effects. This case underscores the potential of combined immunotherapeutic strategies in achieving durable and robust antitumour effects.

Authors and Affiliations

Qing Chen Wang Liu Zhongbin Zhoa

Keywords

Related Articles

Hyper IgM Syndromes: A Brief Review of the Pathogenesis, Clinical Features and Management

Primary Immuno Deficiency (PID) disorders are heterogeneous disorders of the innate or the adaptive immune system, leading to recurrent infections that can also predispose to autoimmune diseases and malignancies. Hyper I...

A Review on Unlocking the Secretes of Immunogenetics

The area of genetics known as immunogenetics focuses on comprehending the immune system's genetic foundation and how it interacts with the human genome. It looks into how immune response to pathogens, immune-related diso...

Hotairm1 Controls S100A9 Protein Phosphorylation in Myeloid-Derived Suppressor Cells during Sepsis

During the acute phase of sepsis, the S100A9 proinflammatory protein resides in the cytosol in a phosphorylated form. In contrast, S100A9 relocalizes to the nucleus in an unphosphorylated form during the late/chronic sep...

A Phylogenomic Analysis of HIV Transmission Pattern among High Risk Groups of North-West India

Background: Molecular techniques can enhance the power of epidemiological investigations for tracing HIV transmission networks. This information could be useful for developing strategies for prevention of HIV transmissio...

Indoleamine 2,3-Dioxygenase (IDO); Silenced Dendritic Cell Vaccine with Ipilimumab in Treating Metastatic Melanoma Patients: A Case Report

Immunotherapy has revolutionized the treatment landscape for metastatic melanoma. This case report presents the clinical course of a patient with metastatic melanoma who received combination therapy with ipilimumab, a CT...

Download PDF file
  • EP ID EP741782
  • DOI 10.35248/2155-9899.23.14.688
  • Views 49
  • Downloads 0

How To Cite

Qing Chen Wang Liu Zhongbin Zhoa (2023). Indoleamine 2,3-Dioxygenase (IDO); Silenced Dendritic Cell Vaccine with Ipilimumab in Treating Metastatic Melanoma Patients: A Case Report. Journal of Clinical & Cellular Immunology, 14(3), -. https://www.europub.co.uk/articles/-A-741782